Emily’s Entourage’s (EE) Translational Grant Program provides critical seed funding to innovative investigators with promising strategies that accelerate research and drug development for those in the final 10% of the CF community who do not benefit from CFTR modulators, including those with rare and nonsense mutations.
The objective of this initiative is to fund promising therapies and drug-delivery mechanisms that have the potential to accelerate the development of gene-based therapies for people with CF.
